| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1993PNAS...90..735M |
| P356 | DOI | 10.1073/PNAS.90.2.735 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC45740 |
| https://www.pnas.org/content/pnas/90/2/735.full.pdf | ||
| https://europepmc.org/articles/PMC45740?pdf=render | ||
| https://pnas.org/doi/pdf/10.1073/pnas.90.2.735 | ||
| P932 | PMC publication ID | 45740 |
| P698 | PubMed publication ID | 7678463 |
| P5875 | ResearchGate publication ID | 15519627 |
| P2093 | author name string | T. Furitsu | |
| A. M. Irani | |||
| L. B. Schwartz | |||
| S. Gillis | |||
| N. Inagaki | |||
| K. Ishizaka | |||
| M. Takei | |||
| K. M. Zsebo | |||
| A. M. Dvorak | |||
| H. Mitsui | |||
| P2860 | cites work | Monoclonal antibodies to human myelomonocyte differentiation antigens in the diagnosis of acute myeloid leukemia | Q70979238 |
| Biochemical analysis of initial triggering events of IgE-mediated histamine release from human lung mast cells | Q72692892 | ||
| Cloning and expression of a cDNA for the human homolog of mouse T cell and mast cell growth factor P40 | Q28304692 | ||
| The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus | Q28512134 | ||
| Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms | Q33258108 | ||
| Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins | Q33564269 | ||
| Development of human mast cells in vitro | Q34326480 | ||
| Interleukin 4 (B-cell stimulatory factor 1) can enhance or antagonize the factor-dependent growth of hemopoietic progenitor cells | Q34350582 | ||
| Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor | Q34567286 | ||
| Two types of human mast cells that have distinct neutral protease compositions | Q35611922 | ||
| The interaction of IgE with rat basophilic leukemia cells. II. Quantitative aspects of the binding reaction | Q36273759 | ||
| A cloned MCGF cDNA encodes a multilineage hematopoietic growth factor: multiple activities of interleukin 3. | Q36388890 | ||
| Antigen-induced increase in protein kinase C activity in plasma membrane of mast cells | Q37557698 | ||
| Monoclonal antibody YB5.B8 identifies the human c-kit protein product. | Q41138789 | ||
| Interleukin 10: a novel stimulatory factor for mast cells and their progenitors | Q41697481 | ||
| The alpha subunit of the human IgE receptor (FcERI) is sufficient for high affinity IgE binding | Q41710083 | ||
| The kit ligand: A cell surface molecule altered in steel mutant fibroblasts | Q41718670 | ||
| Identification of a ligand for the c-kit proto-oncogene | Q41718674 | ||
| Ultrastructural identification of human mast cells resembling skin mast cells stimulated to develop in long-term human cord blood mononuclear cells cultured with 3T3 murine skin fibroblasts. | Q42818857 | ||
| In vitro development and functions of human mast cells | Q42829745 | ||
| An automated continuous-flow system for the extraction and fluorometric analysis of histamine | Q47881145 | ||
| Specificity of a mouse monoclonal antibody raised against acute myeloid leukaemia cells for mast cells in human mucosal and connective tissues. | Q50902819 | ||
| Monoclonal antibodies against human mast cell tryptase demonstrate shared antigenic sites on subunits of tryptase and selective localization of the enzyme to mast cells. | Q50919292 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mast cell | Q191989 |
| P304 | page(s) | 735-739 | |
| P577 | publication date | 1993-01-01 | |
| 1993-01-15 | |||
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand | |
| P478 | volume | 90 |
| Q34371015 | 1995 Mack-Forster Award Lecture. Review. Mast cell differentiation antigens: expression in normal and malignant cells and use for diagnostic purposes. |
| Q34523898 | A possible mechanism of mast cell proliferation in mastocytosis |
| Q43985419 | Acute basophilic leukemia lacking basophil-specific antigens: the importance of cytokine receptor expression in differential diagnosis |
| Q44872907 | An improved procedure for the development of human mast cells from dispersed fetal liver cells in serum-free culture medium |
| Q32100357 | Cell biology of the basophil. |
| Q34066643 | Clinical and biologic diversity of leukemias occurring in patients with mastocytosis. |
| Q34264305 | Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders |
| Q41440970 | Comparative Cytokine Release from Human Monocytes, Monocyte-Derived Immature Mast Cells, and a Human Mast Cell Line (HMC-1) |
| Q71173482 | Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes |
| Q28073836 | Current approach to cutaneous mastocytosis in childhood |
| Q33717312 | Cytokines in asthma |
| Q34663712 | Cytokines regulate development of human mast cells from hematopoietic progenitors |
| Q58751494 | Deciphering the differentiation trajectory from hematopoietic stem cells to mast cells |
| Q30859697 | Detection of c-kit point mutation Asp-816 --> Val in microdissected pooled single mast cells and leukemic cells in a patient with systemic mastocytosis and concomitant chronic myelomonocytic leukemia. |
| Q37373372 | Development of mast cells |
| Q45081017 | Dexamethasone inhibits the development of mast cells from dispersed human fetal liver cells cultured in the presence of recombinant human stem cell factor. |
| Q33948617 | Diagnostic criteria and classification of mastocytosis: a consensus proposal |
| Q71699648 | Differential response of human basophils and mast cells to recombinant chemokines |
| Q40305209 | Effects of chronic treatment with the c-kit ligand, stem cell factor, on immunoglobulin E-dependent anaphylaxis in mice. Genetically mast cell-deficient Sl/Sld mice acquire anaphylactic responsiveness, but the congenic normal mice do not exhibit aug |
| Q71396471 | Effects of cyclosporin A and FK-506 on stem cell factor-induced histamine secretion and growth of human mast cells |
| Q41365558 | Effects of interleukin (IL)-13 on immediate-early response gene expression, phenotype and differentiation of human mast cells. Comparison with IL-4. |
| Q40443526 | Evaluation of normal and neoplastic human mast cells for expression of CD172a (SIRPalpha), CD47, and SHP-1. |
| Q40631611 | Grass pollen immunotherapy decreases the number of mast cells in the skin. |
| Q37871920 | Hematopoietic cytokines for cardiac repair: mobilization of bone marrow cells and beyond |
| Q41761811 | Histamine-releasing factor/translationally controlled tumor protein (HRF/TCTP)-induced histamine release is enhanced with SHIP-1 knockdown in cultured human mast cell and basophil models |
| Q64226685 | Human Mast Cells From Adipose Tissue Target and Induce Apoptosis of Breast Cancer Cells |
| Q91782672 | Human Skin-Derived Mast Cells Spontaneously Secrete Several Angiogenesis-Related Factors |
| Q43759659 | Human mast cell progenitors in peripheral blood from atopic subjects with high IgE levels. |
| Q77398143 | Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: enhanced IL-13 production by IL-4-primed human mast cells |
| Q36380405 | Human peripheral blood eosinophils express a functional c-kit receptor for stem cell factor that stimulates very late antigen 4 (VLA-4)-mediated cell adhesion to fibronectin and vascular cell adhesion molecule 1 (VCAM-1). |
| Q35625454 | Human umbilical cord blood (HUCB) cells for central nervous system repair |
| Q33784323 | Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder |
| Q33646084 | Identification of microRNAs regulating the developmental pathways of bone marrow derived mast cells |
| Q38315689 | Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product |
| Q41040627 | Induction of human leukaemic mast cell differentiation by fibroblast supernatants, but not by stem cell factor |
| Q44032734 | Inhibitory effect of murine kidney extracts on mast cells derived from human umbilical cord blood |
| Q45085248 | KIT signaling is dispensable for human mast cell progenitor development |
| Q36972471 | Leukocytes in glomerular injury |
| Q64069849 | Mast Cell Neural Interactions in Health and Disease |
| Q35560203 | Mast cell proliferative disorders: current view on variants recognized by the World Health Organization |
| Q41119792 | Mast cell-lineage versus basophil lineage involvement in myeloproliferative and myelodysplastic syndromes: diagnostic role of cell-immunophenotyping. |
| Q50068940 | Mast cell-neural interactions contribute to pain and itch |
| Q34657919 | Mast cells, thrombosis, and fibrinolysis: the emerging concept |
| Q33661038 | Mast-cell growth and differentiation |
| Q35994902 | Mastocytosis: pathology, genetics, and current options for therapy |
| Q41120291 | Molecular and functional characterization of the urokinase receptor on human mast cells. |
| Q73039218 | Nerve growth factor release with mast-cell-derived mediators in a patient with systemic mastocytosis after middle-wave ultraviolet irradiation |
| Q73537482 | Nerve growth factor-beta induces mast-cell marker expression during in vitro culture of human umbilical cord blood cells |
| Q34833416 | Oncogenic Kit signals on endolysosomes and endoplasmic reticulum are essential for neoplastic mast cell proliferation |
| Q50766510 | Phenotypic characterization of skin lesions in urticaria pigmentosa and mastocytomas. |
| Q37521998 | Physiological and pathophysiological functions of intestinal mast cells |
| Q89723601 | Rapid identification of human mast cell degranulation regulators using functional genomics coupled to high-resolution confocal microscopy |
| Q36366794 | Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo |
| Q48098372 | Reduced immunostaining for c-kit receptors in mucosal mast cells in inflammatory bowel disease |
| Q33979002 | Regulation of mast cell number and function |
| Q36287476 | Role of human mast cells and basophils in bronchial asthma |
| Q31096289 | Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data |
| Q28586573 | SWAP-70 regulates c-kit-induced mast cell activation, cell-cell adhesion, and migration |
| Q44596933 | Serum inhibitors for human mast cell growth: possible role of retinol |
| Q43650484 | Serum levels of soluble stem cell factor and soluble KIT are elevated in patients with atopic dermatitis and correlate with the disease severity |
| Q33979050 | Serum tryptase and the laboratory diagnosis of systemic mastocytosis |
| Q93037900 | Single-cell analysis reveals the KIT D816V mutation in haematopoietic stem and progenitor cells in systemic mastocytosis |
| Q35609516 | Sphingosine-1-phosphate induces development of functionally mature chymase-expressing human mast cells from hematopoietic progenitors |
| Q73741261 | Stem cell factor in nasal polyposis and allergic rhinitis: increased expression by structural cells is suppressed by in vivo topical corticosteroids |
| Q40399915 | Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes |
| Q71216230 | Stem cell factor-dependent human cord blood derived mast cells express alpha- and beta-tryptase, heparin and chondroitin sulphate |
| Q70869794 | Stem-cell factor, the kit ligand, induces direct degranulation of rat peritoneal mast cells in vitro and in vivo: dependence of the in vitro effect on period of culture and comparisons of stem-cell factor with other mast cell-activating agents |
| Q36715654 | Systemic delivery of umbilical cord blood cells for stroke therapy: a review |
| Q83304407 | Systemic mastocytosis |
| Q57826804 | Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val |
| Q41499733 | TNF-alpha and IL-6 induce differentiation in the human basophilic leukaemia cell line KU812. |
| Q35647500 | The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2. |
| Q38782655 | The development of human mast cells. An historical reappraisal |
| Q88905959 | The development of methods for primary mast cells in vitro and ex vivo: An historical review |
| Q39767830 | The expression of the glucocorticoid receptor in human erythroblasts is uniquely regulated by KIT ligand: implications for stress erythropoiesis. |
| Q34367655 | The history of mast cell and basophil research - some lessons learnt from the last century |
| Q34144555 | The role of mast cells and their mediators in reproduction, pregnancy and labour. |
| Q28191630 | The role of mast cells in asthma |
| Q77741635 | Tumor necrosis factor alpha (TNF-alpha) modulates rat mast cell reactivity |
| Q40904867 | Tumor necrosis factor alpha promotes the expression of stem cell factor in synovial fibroblasts and their capacity to induce mast cell chemotaxis |
Search more.